When would you phlebotomize patients with secondary hemochromatosis, such as due to NAFLD/cirrhosis?  

My simple answer is “rarely, if ever” (but it can get much more complicated). Related to hepcidin changes, patients with chronic liver disease frequently have elevated serum ferritin and transferrin saturation, more so with alcoholic liver disease and non-alcoholic fatty liver disease. I...